Kurt Wheeler, Director, 10% Owner at Somaxon Pharmaceuticals, Inc. (SOMX), sold 72,900 shares at $18.23 ($1.3M) on 2007-05-08, disclosed to the SEC on 2007-05-10.
Scheduled sale ($1.3M) by Director, 10% Owner under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| OXFD | SELL | 2015-03-19 | $2.3M | — | Filing → |
| AERI | BUY | 2015-01-30 | $3.2M | — | Filing → |
| GMED | SELL | 2012-08-10 | $9.0M | — | Filing → |